Dimethyl fumarate possesses antiplatelet and antithrombotic properties
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110381 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Xiang Chu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, X…. Hauptthemen laut MEDLINE: Platelet Activation, Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Shuangchuang Program of Jiangsu Province, National Natural Science Foundation of China, Government of Jiangsu Province.
Abstract (Originalsprache)
BACKGROUND: Dimethyl fumarate (DMF) is a methyl ester of fumaric acid and has been approved for treating multiple sclerosis (MS) and psoriasis due to anti-inflammatory effect. There is a close association between platelets and the pathogenesis of MS. Whether DMF affects platelet function remains unclear. Our study intends to evaluate DMF's effect on platelet function. METHODS: Washed human platelets were treated with different concentrations of DMF (0, 50, 100 and 200 μM) at 37 °C for 1 h followed by analysis of platelet aggregation, granules release, receptors expression, spreading and clot retraction. In addition, mice received intraperitoneal injection of DMF (15 mg/kg) to assess tail bleeding time, arterial and venous thrombosis. RESULTS: DMF significantly inhibited platelet aggregation and the release of dense/alpha granules in response to collagen-related peptide (CRP) or thrombin stimulation dose-dependently without altering the expression of platelet receptors αIIbβ3, GPIbα, and GPVI. In addition, DMF-treated platelets presented significantly reduced spreading on collagen or fibrinogen and thrombin-mediated clot retraction along with the decreased phosphorylation of c-Src and PLCγ2. Moreover, administration of DMF into mice significantly prolonged the tail bleeding time and impaired arterial and venous thrombus formation. Furthermore, DMF reduced the generation of intracellular reactive oxygen species and calcium mobilization, and inhibited NF-κB activation and the phosphorylation of ERK1/2, p38 and AKT. CONCLUSION: DMF inhibits platelet function and arterial/venous thrombus formation. Considering the presence of thrombotic events in MS, our study indicates that DMF treatment for patients with MS might obtain both anti-inflammatory and anti-thrombotic benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Provinc…
Förderung
- Shuangchuang Program of Jiangsu Province
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Project 333 of Jiangsu Province
Zitieren
APA
Chu, X., Zhang, J., Li, Y., Yuan, K., Wang, X., Gui, X., Sun, Y., Geng, C., Ju, W., Xu, M., Li, Z., Zeng, L., Xu, K., & Qiao, J. (2023). Dimethyl fumarate possesses antiplatelet and antithrombotic properties. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110381
Vancouver
Chu X, Zhang J, Li Y, Yuan K, Wang X, Gui X, et al. Dimethyl fumarate possesses antiplatelet and antithrombotic properties. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110381
BibTeX
@article{Chu2023,
author = {Chu, Xiang and Zhang, Jie and Li, Yingying and Yuan, Ke and Wang, Xue and Gui, Xiang and Sun, Yueyue and Geng, Chaonan and Ju, Wen and Xu, Mengdi and Li, Zhenyu and Zeng, Lingyu and Xu, Kailin and Qiao, Jianlin},
title = {Dimethyl fumarate possesses antiplatelet and antithrombotic properties},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110381}
}
EUVIMED